The Food and Drug Administration has approved Yartemlea ® (narsoplimab-wuug) for the treatment of adult and pediatric patients aged 2 years and older with hematopoietic stem cell transplant ...
Kidney disease is very common in patients with cancer. Nephrologists are vital members of the multidisciplinary care team for these patients. Given the high prevalence of comorbidities in patients ...
Paraneoplastic microangiopathic haemolytic anaemia (MAHA) is a rare condition characterised by tumour-driven erythrocyte destruction and platelet consumption. It is uncommon in colorectal cancer (CRC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback